{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:54:50Z","timestamp":1792076090823,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009010","name":"Novartis Pharmaceuticals UK Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.msard.2021.103236","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:48:16Z","timestamp":1630583296000},"page":"103236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Vaccine hesitancy among people with multiple sclerosis"],"prefix":"10.1016","volume":"56","author":[{"given":"Siew Mei","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Al Hinai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Callanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Tubridy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McGuigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msard.2021.103236_bib0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S2352-4642(19)30092-6","article-title":"Vaccine hesitancy: a generation at risk","volume":"3","author":"Health","year":"2019","journal-title":"Lancet Child Adolesc. Health"},{"issue":"4","key":"10.1016\/j.msard.2021.103236_bib0002","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/S2665-9913(21)00037-0","article-title":"Perspective of patients with autoimmune diseases on COVID-19 vaccination","volume":"3","author":"Boekel","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"4","key":"10.1016\/j.msard.2021.103236_bib0003","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00012-8","article-title":"COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics","volume":"6","author":"Schwarzinger","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.msard.2021.103236_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102788","article-title":"Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States","volume":"49","author":"Ehde","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.103236_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102880","article-title":"Willingness to be vaccinated against COVID-19: an exploratory online survey in a Portuguese cohort of multiple sclerosis patients","volume":"51","author":"Serrazina","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2021.103236_bib0006","first-page":"435","article-title":"Protecting people with multiple sclerosis through vaccination","author":"Reyes","year":"2020","journal-title":"Pract. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2021.103236_bib0007","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1352458520952310","article-title":"Vaccinations in patients with multiple sclerosis: a Delphi consensus statement","author":"Riva","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2021.103236_bib0008","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coviro.2020.05.009","article-title":"Waning immunity and re-emergence of measles and mumps in the vaccine era","volume":"40","author":"Yang","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.msard.2021.103236_bib0009","doi-asserted-by":"crossref","DOI":"10.1177\/1352458521991433","article-title":"Human papillomavirus lesions in 16 MS patients treated with fingolimod: outcomes and vaccination","author":"Mhanna","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2021.103236_bib0010","unstructured":"Department of Health. Update on COVID-19 vaccine deliveries \u201310 March 2021. https:\/\/www.gov.ie\/en\/press-release\/94db0-update-on-covid-19-vaccine-deliveries-10-march-2021\/ (accessed 14 June 2021)."},{"key":"10.1016\/j.msard.2021.103236_bib0011","unstructured":"Health Service Executive. Flu. 2021a https:\/\/www.hse.ie\/eng\/health\/immunisation\/pubinfo\/adult\/fluva\/ (accessed 14 June 2021)."},{"key":"10.1016\/j.msard.2021.103236_bib0012","unstructured":"Health Service Executive. Pneumococcal Disease. 2021b https:\/\/www.hse.ie\/eng\/health\/immunisation\/pubinfo\/adult\/pneumo\/ (accessed 14 June 2021)."},{"key":"10.1016\/j.msard.2021.103236_bib0013","unstructured":"Health Service Executive. HPV vaccination programme. 2021c https:\/\/www.hse.ie\/eng\/health\/immunisation\/pubinfo\/schoolprog\/hpv\/hpv-vaccination-programme\/hpv-vaccination-programme.html (accessed 14 June 2021)."},{"key":"10.1016\/j.msard.2021.103236_bib0014","unstructured":"Health Service Executive. Measles, mumps and rubella. 2021d https:\/\/www.hse.ie\/eng\/health\/immunisation\/pubinfo\/pcischedule\/vpds\/mmr\/ (accessed 14 June 2021)."},{"issue":"8","key":"10.1016\/j.msard.2021.103236_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1479-5876-8-105","article-title":"HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future","volume":"27","author":"Mariani","year":"2010","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.msard.2021.103236_bib0016","first-page":"125","article-title":"Behaviorally informed strategies for a national COVID-19 vaccine promotion program","volume":"325","author":"Volpp","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.msard.2021.103236_bib0017","article-title":"The digital immunization system of the future: imagining a patient-centric, interoperable immunization information system","volume":"8","author":"Atkinson","year":"2020","journal-title":"Ther. Adv. Vaccines Immunother."},{"issue":"34","key":"10.1016\/j.msard.2021.103236_bib0018","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1016\/j.vaccine.2015.04.037","article-title":"SAGE working group on vaccine hesitancy. Measuring vaccine hesitancy: The development of a survey tool","volume":"33","author":"Larson","year":"2015","journal-title":"Vaccine"},{"issue":"10255","key":"10.1016\/j.msard.2021.103236_bib0019","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","article-title":"Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study","volume":"396","author":"de Figueiredo","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2021.103236_bib0020","first-page":"1","article-title":"Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China","volume":"26","author":"Akel","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"issue":"13","key":"10.1016\/j.msard.2021.103236_bib0021","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.vaccine.2021.02.039","article-title":"A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines","volume":"39","author":"Helmkamp","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.msard.2021.103236_bib0022","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.dsx.2021.04.004","article-title":"Development and validation of a questionnaire to assess knowledge, attitude, practices, and concerns regarding COVID-19 vaccination among the general population","volume":"15","author":"Kumari","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"issue":"1","key":"10.1016\/j.msard.2021.103236_bib0023","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1186\/s12889-021-11098-9","article-title":"Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada","volume":"21","author":"Ogilvie","year":"2021","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.msard.2021.103236_bib0024","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","article-title":"A global survey of potential acceptance of a COVID-19 vaccine","volume":"27","author":"Lazarus","year":"2021","journal-title":"Nat. Med."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821005034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821005034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:59:11Z","timestamp":1761901151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821005034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":24,"alternative-id":["S2211034821005034"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103236","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine hesitancy among people with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103236"}}